Abstract:Background: Hypoxia-regulated proteins (HIF-1α and GLUT-1) have been identified as prognostic markers in various cancers; however, their role in endometrial cancer remains unclear. This study aimed to evaluate HIF-1α and GLUT-1 expression in endometrial cancer and correlate their expression with clinicopathological features. Materials and methods: A tissue microarray (TMA) was constructed using specimens from a retrospective cohort of 51 endometrial cancer patients who underwent hysterectomy at the Gyeongsang National University Hospital between 2002 and 2009. Clinicopathologic data were collected from electronic medical records, and HIF-1α and GLUT-1 expressions were assessed in the tumor tissue. Results: GLUT-1 expression in endometrial cancer was categorized as mosaic, central, or diffuse. Most patients (56.0%) exhibited a central pattern, followed by diffuse (32.0%) and mosaic (12.0%) patterns. GLUT-1 expression was not significantly associated with histologic grade (p = 0.365). HIF-1α expression in immune cells, but not tumor cells, was significantly associated with a higher histologic grade. A higher proportion of HIF-1α-positive immune cells, using both thresholds (≤1% vs. >1% and ≤5% vs. >5%), was significantly associated with higher histologic grade (p = 0.032 and p = 0.048, respectively). In addition, a higher proportion of HIF-1α-positive immune cells was significantly associated with a diffuse GLUT-1 expression pattern using >5% as a threshold. There were no significant differences in the proportion of HIF-1α-positive immune cells between groups stratified by age, tumor size, or invasion depth, regardless of whether the 1% or 5% threshold for HIF-1α positivity was used. Conclusions: A higher proportion of HIF-1α-positive immune cells is associated with endometrial cancers with higher histologic grade and diffuse GLUT1 expression patterns. These findings suggest a potential role for HIF-1α as a prognostic marker and highlight the need for further studies into the role of HIF-1α in the tumor microenvironment.

The expressions of HSFl and XAF1 in endometrial carcinoma and their correlation analysis

Expression of FHIT Protein,ki-67 and Their Significance in Endometrial Carcinoma

Expression of DACH1,fatty acid synthase and sterol regulatory element binding protein-1 in endometrial carcinoma

[Expression and Clinical Significance of Beclin1 and PTEN in Endometrial Carcinoma].

Study on the Expression of HIF-1α and VEGF in Endometrial Adenocarcinoma and Their Relationship

Expression and significance of LC3 and cathepsin D in human endometrioid adenocarcinoma.

[Expressions of Stromal Cell-Derived Factor-1 and CXCR4 in Endometrial Carcinoma Tissues and Cell Lines].

The Expression of Fragile Histidine Triad Protein in Endometrial Carcinomas

Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma

Angiogenesis related gene expression profiles of human endometrial endothelial cells isolated from tissue of endometrial cancer]

Expression and significance of SPARC, E-cadherin and EZH2 in endometrial carcinoma

Expression of TBX2 and PAX9 in endometrial adenocarcinomas and their correlation

Expression of Heat Shock Protein (HSP70) in Normal Endometrium and Endometrial Carcinomas

Expression of heat shock factor 1 and its relation with prognosis in breast cancer patients

Correlation Between the Overexpression of Epidermal Growth Factor Receptor and Mesenchymal Makers in Endometrial Carcinoma.

The Expression of Hypoxia Inducible Factor-1α in the Endometrium of Patients with Endometriosis

Expressions of Id-1,Smad4 and p21~(WAF1/CIP1) protein and mRNA in endometrial adenocarcinomas and their significance

Expressions of growth factor receptor binding protein 7 and human epidermal growth factor receptor 2 in endometrial carcinoma and their significances

Study on the expression of hMLH1 gene in endometrial carcinoma

Insulin-like Growth Factors in Endometrioid Adenocarcinoma: Correlation with Clinico-Pathological Features and Estrogen Receptor Expression

Hypoxia-Regulated Proteins: Expression in Endometrial Cancer and Their Association with Clinicopathologic Features